SCHEMBL6496819

SCHEMBL6496819

COc1ccc(/C=C/C(=O)N2CCC(C(=O)NC(C)C(=O)O)CC2)c(C)c1C

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.48
NPC1 O15118 6/20 0.46
RAB9A P51151 6/20 0.46
APOBEC3A P31941 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
ITGAL P20701 6/20 0.44
ITGB2 P05107 3/20 0.44
ICAM1 P05362 3/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
CAPN1 P07384 3/20 0.44
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 1/20 0.42
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496828 1.00 KDM4E (0.48) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6497407 0.94 KDM4E (0.46) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6497398 0.94 KDM4E (0.46) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6502822 0.90 NPC1 (0.46) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6502814 0.90 NPC1 (0.46) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6498439 0.88 ITGAL (0.51) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6498445 0.88 ITGAL (0.51) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6504728 0.87 ITGAL (0.54) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6504723 0.87 ITGAL (0.54) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G
SCHEMBL6506076 0.85 KMT2A (0.54) KDM4ENPC1RAB9AAPOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed